Skip to main content

Adherence in the treatment of HIV and other infectious diseases

Publication ,  Journal Article
Goldstein, KM
December 1, 2010

Over the last decade, survival in patients with human immunodeficiency virus (HIV) has lengthened dramatically due to improvements in the robust options for antiretroviral therapy (ART) [1]. Clinicians caring for HIV-positive patients now face many of the same challenges encountered by those with other chronic conditions (e.g., cardiovascular disease, complications from diabetes, aging) [2]. One particular issue that plagues all clinicians caring for patients with chronic diseases is how to promote optimal adherence to prescribed treatment over time. Adherence to treatment for HIV has some unique features that make its assessment and measurement challenging. In this chapter, we will review the ways in which this disease differs from and is similar to other chronic diseases. Lastly, we will identify methods and techniques that clinicians may use to enhance adherence among individuals with HIV. Of note, we will be specifically focusing on issues pertaining to the treatment of HIV in the USA. © 2010 Springer Science+Business Media, LLC.

Duke Scholars

DOI

Publication Date

December 1, 2010

Start / End Page

259 / 288
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goldstein, K. M. (2010). Adherence in the treatment of HIV and other infectious diseases, 259–288. https://doi.org/10.1007/978-1-4419-5866-2_11
Goldstein, K. M. “Adherence in the treatment of HIV and other infectious diseases,” December 1, 2010, 259–88. https://doi.org/10.1007/978-1-4419-5866-2_11.
Goldstein, K. M. Adherence in the treatment of HIV and other infectious diseases. Dec. 2010, pp. 259–88. Scopus, doi:10.1007/978-1-4419-5866-2_11.

DOI

Publication Date

December 1, 2010

Start / End Page

259 / 288